Eagle Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,832,549
| Closed | -$34.5M | – | 642 |
|
|
2017
Q3 | $34.5M | Sell |
2,832,549
-28,516
| -1% | -$347K | 0.2% | 174 |
|
|
2017
Q2 | $47.1M | Buy |
2,861,065
+8,756
| +0.3% | +$144K | 0.28% | 128 |
|
|
2017
Q1 | $40.9M | Sell |
2,852,309
-14,307
| -0.5% | -$205K | 0.26% | 126 |
|
|
2016
Q4 | $39.6M | Buy |
2,866,616
+1,138,662
| +66% | +$15.7M | 0.26% | 123 |
|
|
2016
Q3 | $31.2M | Buy |
1,727,954
+49,222
| +3% | +$889K | 0.21% | 148 |
|
|
2016
Q2 | $24.1M | Buy |
1,678,732
+196,759
| +13% | +$2.82M | 0.17% | 181 |
|
|
2016
Q1 | $17.7M | Buy |
1,481,973
+867,419
| +141% | +$10.4M | 0.12% | 237 |
|
|
2015
Q4 | $8.43M | Buy |
+614,554
| New | +$8.43M | 0.06% | 355 |
|